CDXS
Price
$2.37
Change
+$0.11 (+4.87%)
Updated
Jun 6 closing price
Capitalization
187.23M
53 days until earnings call
ELDN
Price
$3.08
Change
+$0.10 (+3.36%)
Updated
Jun 6 closing price
Capitalization
178.15M
60 days until earnings call
Interact to see
Advertisement

CDXS vs ELDN

Header iconCDXS vs ELDN Comparison
Open Charts CDXS vs ELDNBanner chart's image
Codexis
Price$2.37
Change+$0.11 (+4.87%)
Volume$698.67K
Capitalization187.23M
Eledon Pharmaceuticals
Price$3.08
Change+$0.10 (+3.36%)
Volume$198.17K
Capitalization178.15M
CDXS vs ELDN Comparison Chart
Loading...
CDXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CDXS vs. ELDN commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDXS is a Hold and ELDN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (CDXS: $2.33 vs. ELDN: $3.15)
Brand notoriety: CDXS and ELDN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CDXS: 67% vs. ELDN: 65%
Market capitalization -- CDXS: $187.23M vs. ELDN: $178.15M
CDXS [@Biotechnology] is valued at $187.23M. ELDN’s [@Biotechnology] market capitalization is $178.15M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CDXS’s FA Score shows that 0 FA rating(s) are green whileELDN’s FA Score has 0 green FA rating(s).

  • CDXS’s FA Score: 0 green, 5 red.
  • ELDN’s FA Score: 0 green, 5 red.
According to our system of comparison, both CDXS and ELDN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CDXS’s TA Score shows that 3 TA indicator(s) are bullish while ELDN’s TA Score has 4 bullish TA indicator(s).

  • CDXS’s TA Score: 3 bullish, 5 bearish.
  • ELDN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ELDN is a better buy in the short-term than CDXS.

Price Growth

CDXS (@Biotechnology) experienced а -0.43% price change this week, while ELDN (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

CDXS is expected to report earnings on Jul 31, 2025.

ELDN is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CDXS($187M) and ELDN($178M) have the same market capitalization . ELDN YTD gains are higher at: -23.544 vs. CDXS (-51.153). CDXS has higher annual earnings (EBITDA): -53.41M vs. ELDN (-70.22M). ELDN has more cash in the bank: 140M vs. CDXS (73.5M). ELDN has less debt than CDXS: ELDN (954K) vs CDXS (59.9M). CDXS has higher revenues than ELDN: CDXS (59.3M) vs ELDN (0).
CDXSELDNCDXS / ELDN
Capitalization187M178M105%
EBITDA-53.41M-70.22M76%
Gain YTD-51.153-23.544217%
P/E RatioN/A4.81-
Revenue59.3M0-
Total Cash73.5M140M53%
Total Debt59.9M954K6,279%
FUNDAMENTALS RATINGS
CDXS vs ELDN: Fundamental Ratings
CDXS
ELDN
OUTLOOK RATING
1..100
2518
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
40
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9897
PRICE GROWTH RATING
1..100
6463
P/E GROWTH RATING
1..100
10080
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ELDN's Valuation (40) in the Pharmaceuticals Major industry is in the same range as CDXS (46) in the Chemicals Specialty industry. This means that ELDN’s stock grew similarly to CDXS’s over the last 12 months.

ELDN's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as CDXS (100) in the Chemicals Specialty industry. This means that ELDN’s stock grew similarly to CDXS’s over the last 12 months.

ELDN's SMR Rating (97) in the Pharmaceuticals Major industry is in the same range as CDXS (98) in the Chemicals Specialty industry. This means that ELDN’s stock grew similarly to CDXS’s over the last 12 months.

ELDN's Price Growth Rating (63) in the Pharmaceuticals Major industry is in the same range as CDXS (64) in the Chemicals Specialty industry. This means that ELDN’s stock grew similarly to CDXS’s over the last 12 months.

ELDN's P/E Growth Rating (80) in the Pharmaceuticals Major industry is in the same range as CDXS (100) in the Chemicals Specialty industry. This means that ELDN’s stock grew similarly to CDXS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CDXSELDN
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 12 days ago
85%
Bearish Trend 12 days ago
90%
Momentum
ODDS (%)
Bearish Trend 12 days ago
82%
Bullish Trend 12 days ago
89%
MACD
ODDS (%)
N/A
Bullish Trend 12 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
83%
Bullish Trend 12 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 12 days ago
83%
Bearish Trend 12 days ago
90%
Advances
ODDS (%)
Bullish Trend 13 days ago
85%
Bullish Trend 19 days ago
83%
Declines
ODDS (%)
Bearish Trend 21 days ago
84%
Bearish Trend 28 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 12 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 12 days ago
77%
Bearish Trend 12 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
CDXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

CDXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDXS has been loosely correlated with DNLI. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if CDXS jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDXS
1D Price
Change %
CDXS100%
-8.63%
DNLI - CDXS
53%
Loosely correlated
-1.29%
PRAX - CDXS
48%
Loosely correlated
+2.58%
ABCL - CDXS
46%
Loosely correlated
+3.03%
BEAM - CDXS
46%
Loosely correlated
-0.88%
CRSP - CDXS
44%
Loosely correlated
-0.92%
More

ELDN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELDN has been loosely correlated with CDXS. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ELDN jumps, then CDXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELDN
1D Price
Change %
ELDN100%
N/A
CDXS - ELDN
38%
Loosely correlated
-8.63%
AMLX - ELDN
36%
Loosely correlated
+1.48%
ABSI - ELDN
36%
Loosely correlated
+0.74%
RVMD - ELDN
36%
Loosely correlated
+2.04%
DNLI - ELDN
36%
Loosely correlated
-1.29%
More